Related Experiment Video
Updated: Jun 30, 2026
In Utero Intra-cardiac Tomato-lectin Injections on Mouse Embryos to Gauge Renal Blood Flow
Published on: February 4, 2015
Bleeding experience with medication abortion prior to embryonic cardiac activity
Alena Kathryn Hoover1, Megan Alicia Cohen1, Miranda Lynn Martin Delawalla1
1Emory University School of Medicine, Department of Gynecology and Obstetrics, Woodruff Memorial Research Building, 101 Woodruff Circle, Suite 4208, Atlanta, GA 3032, United States.
Objectives:
To elucidate the patient experience with medication abortion prior to the detection of embryonic cardiac activity (ECA). We characterized the duration and intensity of bleeding and cramping, pregnancy symptoms, functional recovery, and efficacy.
Study Design:
This was a prospective cohort study. A series of eight electronic surveys were administered from abortion initiation through six weeks. Chart abstraction was performed to obtain demographic and baseline clinical information and to verify follow-up data. Descriptive statistics characterized patient experience and bivariate analyses were conducted to identify potential predictors of patient experience.
Results:
We enrolled 250 participants between July 2024 and March 2025. At baseline, 183/250 (73%) of respondents reported typically moderate menses and 185/250 (74%) reported pregnancy symptoms. At some point during the first three days, 130/207 (63.1%) reported bleeding heavier than menses and 144/201 (71.6%) reported pain or cramping heavier than menses. Nulliparity (p < 0.001) and crown rump length (CRL; p = 0.048) were significantly associated with heavier cramping vs. usual or lighter cramping than menses. Of participants who had pregnancy symptoms at baseline, 49/124 (39.5%) still had pregnancy symptoms at two weeks. The mean time to functional recovery was 5.8 days. Complication rates were low.
Conclusions:
Bleeding and cramping with medication abortion prior to ECA were reported as heavier than menses less frequently than previously shown for patients undergoing medication abortion later in the first trimester. Bleeding expectations discussed during counseling can therefore be adjusted and reassurance can be provided to patients who experience bleeding and cramping less than or similar to menses.
Implications:
With the implementation of abortion bans at ECA, more patients will only have access to abortion care at very early gestational duration (GD). Patient counseling on medication abortion expectations and follow-up care can be tailored to reflect the differences noted in this study.
